Received Mar 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | W031448 | — |
No additional adverse event; An office manager called to report an AE where a dose of GARDASIL 9 was administered to a patient after it's expiration date. No additional information provided to further clarify the details. No additional adverse effects reported. No additional AE; This spontaneous report was received from a consumer and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications and previous drugs reactions or allergies were not reported. On 25-FEB-2025, the patient was vaccinated with an expired dose of human papillomavirus 9-valent vaccine, recombinant suspension for injection (GARDASIL 9) administered as prophylaxis (Lot No. W031448 has been verified to be a valid lot number for [human papillomavirus 9-valent vaccine, recombinant suspension for injection], expiration date reported and upon internal validation established as 12-FEB-2025) (strength, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided) (expired product administered). No additional adverse event was reported (no adverse event).